Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | Chief Financial Officer | $3.03M | -$33.5K | -1.1% | Feb 10, 2025 |
OPTN | OptiNose, Inc. | Chief Financial Officer | $163K | Mar 16, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|